Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

53 results about "Propranolol Hydrochloride" patented technology

The hydrochloride form of propranolol, a synthetic beta-adrenergic receptor blocker with antianginal, antiarrhythmic, and antihypertensive properties. Propranolol competitively antagonizes beta-adrenergic receptors, thereby inhibiting beta-adrenergic reactions, such as vasodilation, and negative chronotropic and inotropic effects.

Propranolol hydrochloride gel for treating infant superficial hemangioma

The invention belongs to the technical field of medicines, and provides a propranolol hydrochloride (PPL.HCL) gel which can be externally used for treating infant superficial hemangioma. The propranolol hydrochloride gel is mainly prepared from propranolol hydrochloride, gel matrix, a percutaneous penetration enhancer, a preservative, a humectant and the like. By using the propranolol hydrochloride gel, adverse reactions such as decreased heart rate, cyanosis, airway hyperresponsiveness, shortage of granular leukocytes, diarrhoea, sleep change and blood sugar reduction caused by orally taking propranolol by hemangioma patients can be reduced and even avoided, and the problems that oral dosage is not easy to control, infants inconveniently take medicines and the like are solved.
Owner:XIANGYA HOSPITAL CENT SOUTH UNIV

Extended release dosage forms of propranolol hydrochloride

A unit dosage form, such as a capsule or the like for delivering drugs into the body in a sustained release fashion similar to that produced by INDERAL® LA indicated for the treatment of cardiovascular diseases, comprises two populations of propranolol-containing particles (beads, pellets, granules, etc.). Each bead population exhibits a pre-designed rapid release profile (i.e., substantially complete release within 60 minutes) or sustained release profile over a period of 24 hours. Such a cardiovascular drug delivery system is designed by combining immediate release (IR) beads and sustained release (SR) beads. SR beads may be obtained by membrane coating IR beads with a water-insoluble polymer such as ethylcellulose or a mixture of a water insoluble polymer and a water-soluble polymer such as hydroxypropylcellulose at a ratio of from about 65 / 35 to 95 / 5.
Owner:ADARE PHARM INC

Propranolol hydrochloride lipidosome gel and preparation method thereof

The invention discloses a propranolol hydrochloride lipidosome gel, which is prepared by the following bulk drugs and auxiliary materials by weight percent: 0.012-0.075% of propranolol hydrochloride, 0.037-0.150% of phosphatidyl ethanolamine, 0.012-0.075% of cholesterol, 2.5-5% of triethanolamine, 1-2% of carbopol, and the balance of water. According to the propranolol hydrochloride lipidosome gel, during the preparation, the lipidosome is uniformly dispersed in the gel, so that the stability of the lipidosome is improved; the water-soluble gel carbopol has excellent biocompatibility, can be well adhered to skin and cannot stimulate skin; drug administration time is prolonged, the toxic and side effects on the whole body are reduced, the adaptability of patients is improved, and the propranolol hydrochloride lipidosome gel has excellent application prospect.
Owner:SHANDONG UNIV

Timolol maleate potentiometric chemical sensor and preparation method thereof

The invention relates to and belongs to a potentiometric chemical sensor, in particular to a timolol maleate potentiometric chemical sensor and a preparation method thereof. The preparation method comprises the following steps: (1) carrying out the chemical modification by the periodic scanning electro-polymerization method after pre-processing the surface of the matrix electrode to prepare the chemically modified electrode; (2) preparing a PVC-film sensitive solution by the conventional method with the solvent being tetrahydrofuran, and coating the modified electrode with the PVC sensitive film by the dip-coating method to prepare a chemical sensor (I); (3) preparing the molecularly imprinted polymer (Polymer A) of timolol maleate, and preparing the PVC film (Film II) containing Polymer A; and (4) compounding the Film II onto the PVC sensitive film of the chemical sensor I. The invention can effectively overcome the disadvantages of the existence of internal reference solution electrodes in the prior art, furthermore, the chemical sensor of the invention is significantly superior to the existing ion-selective electrodes in term of the selectivity of the drug (such as propranolol hydrochloride and the like) ions with the molecule with the structures, such as alcohol amine, imido and the like.
Owner:溧阳常大技术转移中心有限公司

Propranolol hydrochloride cream used for treating infantile hemangioma, and preparation method thereof

The invention discloses a propranolol hydrochloride cream used for treating infantile hemangioma, and a preparation method thereof. The cream comprises the components of, by weight, 0.8-1.2% of propranolol hydrochloride, 5.5-8% of octadecanol, 5.5-8% of glycerol monostearate, 5.5-8% of stearic acid, 7.5-10.5% of liquid paraffin, 7.5-10.5% of glycerol, 7.5-10.5% of propylene glycol, 1.5-2.5% of an emulsifier, 0.4-0.6% of a penetration enhancer, 0.08-0.12% of a preservative, and balance of water. The propranolol hydrochloride cream provided by the invention has good stability, and an effective duration of at least 24 months. The cream can directly act upon an infection site, such that local medicine concentration is high, and adverse reactions caused by oral administration or intravenous administration can be avoided. With the cream, medicine effect can be maximized, and medicine side effect can be reduced. The cream has a definite effect, and is suitable for industrialized large-scale productions. The cream is used for treating hemangioma and is especially suitable for treating infantile hemangioma.
Owner:GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND

Transdermal drug administering system

The invention discloses a percutaneous give drug system, which comprises: a drug storeroom, the gel drug layer comprises drug, solvent, transdermal accelerating agent and gelatinizing agent; one adsorption layer comprised solvent absorption material of solvent in absorbable drug storeroom; one isolating layer between drug storeroom and adsorption layer, which is of non-woven fabrics or semipermeable membrane to make solvent of gas or liquid pass through successfully; adsorption layer can joint isolating layer of drug storeroom in opposite directions of closing up to skin of drug storeroom. The percutaneous give drug system in this invention can increase drug level in drug storeroom of the system to elevate drug transdermal speed, as well as increase controlled release effect of percutaneous give drug and absolute bioavailability, enhance drug curative effect, decrease drug waste, and depress preparation cost of the system. The invention is fit particular to percutaneous give drug system for water-soluble drug of propranolol hydrochloride, verapamil hydrochloride and chlorpromazine hydrochloride.
Owner:HANGZHOU MINSHENG PHARM CO LTD

Propranolol hydrochloride submicron emulsion gel and preparation method and application thereof

The invention discloses propranolol hydrochloride submicron emulsion gel and a preparation method and application thereof. The propranolol hydrochloride submicron emulsion gel comprises propranolol hydrochloride and pharmaceutical acceptable medicinal excipients, wherein the medicinal excipients comprise oil, a surfactant, a cosurfactant, a penetration enhancer, a gel substrate, a pH conditioning agent and the balance water. The propranolol hydrochloride submicron emulsion gel can efficiently deliver the propranolol hydrochloride to skin tissue to enable drugs to be released slowly, skin targeted drug delivery treatment on superficial infantile hemangioma is achieved, and the problems that for an existing drug, the curative effect is low, the side effect is large, and the transdermal absorption ratio is low are effectively solved.
Owner:WUHAN CONFORM PHARMA CO LTD +1

Propranolol hydrochloride gel for treating infant superficial hemangioma

ActiveCN102871956BGood percutaneous penetrationAchieving local therapeutic concentrationsOrganic active ingredientsAerosol deliveryDecreasing heart rateBlood sugar
The invention belongs to the technical field of medicines, and provides a propranolol hydrochloride (PPL.HCL) gel which can be externally used for treating infant superficial hemangioma. The propranolol hydrochloride gel is mainly prepared from propranolol hydrochloride, gel matrix, a percutaneous penetration enhancer, a preservative, a humectant and the like. By using the propranolol hydrochloride gel, adverse reactions such as decreased heart rate, cyanosis, airway hyperresponsiveness, shortage of granular leukocytes, diarrhoea, sleep change and blood sugar reduction caused by orally taking propranolol by hemangioma patients can be reduced and even avoided, and the problems that oral dosage is not easy to control, infants inconveniently take medicines and the like are solved.
Owner:XIANGYA HOSPITAL CENT SOUTH UNIV

Preparation method of propranolol hydrochloride single enantiomers

The invention relates to a preparation method of propranolol hydrochloride single enantiomers, comprising the following steps of: (1) preparing a saturated solution from a raw material drug of propranolol hydrochloride raceme; (2) injecting the saturated solution to a high efficiency liquid chromatography system, and separating according to conditions that n-hexane-ethanol-isopropanol-diethylamine is used as a mobile phase and a chiral chromatographic column is used as a stationary phase to obtain propranolol enantiomer fraction A and fraction B within different peak value ranges of a chromatogram map; (3) concentrating and then evaporating the propranolol enantiomer fraction A and fraction B respectively to obtain propranolol hydrochloride single enantiomer crude products A and B; (4) adding n-butyl to the propranolol hydrochloride single enantiomer crude products A and B respectively, and dissolving by heating to form hot saturated solutions A and B; and (5) filtering, cooling and drying the hot saturated solutions A and B respectively to obtain propranolol hydrochloride single enantiomers A and B. The preparation method of the invention is simple in process and can simultaneously obtain two enantiomers with high optical rotation purity at a high yield.
Owner:王荣

Medicine composition for treating insomnia

The invention relates to medicine composition for treating insomnia, which consists of following ingredients in parts by weight: 15 to 35 parts of Chinese angelica, 10 to 30 parts of roots of red-rooted salvia, 15 to 30 parts of radix curcumae, 10 to 25 parts of polygala tenuifolia, 5 to 23 parts of liquorice, 10 to 28 parts of poria with hostwood, 15 to 33 parts of fried spina date seeds, 1 to 15 parts of fructus alpiniae oxyphyllae, 5 to 23 parts of pericarpium citri reticulatae, 4 to 22 parts of platycladi seeds, 6 to 24 parts of calamus, 5 to 23 parts of dragon bone, 15 to 33 parts of rheum officinale, 1 to 15 parts of ligusticum wallichii, 2 to 18 parts of schisandra chinensis, 5 to 23 parts of radix paeoniae alba, 2 to 18 parts of Cape jasmine, 10 to 28 parts of cortex albiziae, 0.4 to 0.7 part of propranolol hydrochloride, 0.4 to 0.7 part of oryzanol and 0.2 to 0.3 part of diazepam tablets. The medicine composition has a function for treating nervous insomnia caused by various reasons, refractory insomnia and insomnia with unknown reasons; and moreover, the medicine composition is remarkable in curative effect, short in treatment process, fast in effectiveness and free from side effect.
Owner:郭秀翠

Propranolol hydrochloride oral administration emulsion and preparation method thereof

ActiveCN106474061AOvercome narrownessGet over taking tabletsOrganic active ingredientsPharmaceutical non-active ingredientsThroatOver treatment
The invention relates to a propranolol hydrochloride oral administration emulsion for treating infantile hemangioma and a preparation method thereof. The oral administration emulsion is prepared from 0.25 to 40 parts by weight of propranolol hydrochloride, 70 to 300 parts by weight of oil phase, 22 to 200 parts by weight of emulsifiers, 15 to 101.5 parts by weight of co-emulsifiers and 352 to 1570 parts by weight of purified water. The propranolol hydrochloride oral administration emulsion provided by the invention solves the problem that no special oral administration preparation for treating infantile hemangioma exists in China at present. The propranolol hydrochloride oral administration emulsion provided by the invention overcomes the defect of a phenomenon of tablet and capsule taking difficulty due to infant pharyngeal narrowing. The propranolol hydrochloride is used as an effective ingredient to be uniformly dispersed in the emulsion; the administration dosage can be precisely mastered; the excessive treatment or insufficient treatment can be avoided.
Owner:黑龙江童医生儿童生物制药有限公司

HPLC detection method for propranolol hydrochloride genotoxic impurities

The invention relates to an HPLC (High Performance Liquid Chromatography) detection method for propranolol hydrochloride genotoxic impurities. The method comprises the following steps of: preparing amixed reference substance mother solution from 1-naphthol, naphthyl glycidyl ether and a diluent in a constant-volume manner; preparing a sample solution from propranolol hydrochloride and a diluent in a constant-volume mode; and detecting the mixed reference substance mother solution and the sample solution by adopting a high performance liquid chromatograph to obtain a qualitative and quantitative detection result of propranolol hydrochloride genotoxic impurities 1-naphthol and naphthyl glycidyl ether, wherein the conditions of high performance liquid chromatography as follows: a C18 chromatographic column is adopted; and gradient elution is carried out by taking a phosphoric acid aqueous solution as a mobile phase A and acetonitrile as a mobile phase B at the column temperature of 20-30DEG C and the detection wavelength of 215-220nm. The method has the advantages of good specificity, solution stability, sensitivity, linearity, accuracy, precision and durability, appropriate chromatographic conditions and good separation effect, can meet the requirements of qualitative and quantitative detection, and is beneficial to quality control of genotoxic impurities 1-naphthol and naphthyl glycidyl ether in API so as to monitor the quality of drugs.
Owner:JIANGSU YUNYANG PHARMA GRP

Propranolole hydrochloride sustained-release pellets and preparation method thereof

The invention discloses propranolole hydrochloride sustained-release pellets and a preparation method thereof. The propranolole hydrochloride sustained-release pellets comprise a coating layer, medicine-containing pellets, Eudragit NE-30D, powdered steatile, sodium dodecyl sulfate or polyethylene glycol; propranolole hydrochloride, blank pellets, a filler, a lubricant and an adhesive. The method employs a novel sustained release preparation and a pellets preparation, slow release means delay of drug release rate of the medicine in a dosage form, absorption rate of medicine in the body can be reduced, more stable treatment effect can be realized; pellets can increase the distribution area of the medicine on the surface of the gastrointestinal tract, irritation is reduced, bioavailability is increased, influence due to stomach evacuation factor is not generated, medicine can be uniformly absorbed in the body, individual difference is little, and simultaneous application of two advanced technologies enhances the technical advantage of the propranolole hydrochloride sustained-release pellets.
Owner:HARBIN SHENGJI PHARMA

Propranolol hydrochloride gel preparation for external use and preparation method and application thereof

The invention provides a propranolol hydrochloride gel preparation for external use and a preparation method and application thereof. The propranolol hydrochloride gel preparation for the external use contains at least 3% by weight of propranolol hydrochloride. The propranolol hydrochloride gel preparation for the external use has good stability and skin permeability and has a significant curative effect on treatment and prevention of infantile hemangioma located in different subcutaneous depths.
Owner:WUHAN CONFORM PHARMA CO LTD

Electric potential type chemical sensor and preparation method of full solid-state hydrochloric acid propranolol

ActiveCN101178376AEliminate internal reference solutionGood linear response rangeMaterial analysis by electric/magnetic meansDip-coatingPyrrole
The invention relates to an all-solid-state propranolol hydrochloride potential chemical sensor and a preparation method thereof, and the chemical sensor can be directly applied in the field of drug (drug analysis) and analytical chemistry. The preparation method includes the following three steps: (1) the invention adopts a circulation scanning electrical polymerization method to carry out a chemical modification to a metal matrix electrode, so as to prepare a chemically modified electrode; (2) the invention takes tetrahydrofuran as a solvent, and the PVC sensitive (film) liquid is prepared by using a conventional method; (3) the PVC sensitive film is coated on the modified electrode by using a dip-coating method. Thus, the all-solid-state propranolol hydrochloride ion selective electrode is prepared. When in electrode modification, the used pyrrole solution contains sillicontungstic acid-sulfuric acid with a certain concentration; the invention effectively solves the shortcoming of the containing of the inner reference solution in the prior art, and the invention is superior to the performances of the existing ion selective electrodes.
Owner:溧阳常大技术转移中心有限公司

Propranolol hydrochloride drop pills and its preparation method

The invention uses super micro shattering and propranolol drop pills producing the technology to produce fenfluramine drop pills, reaching the purposes such as increasing speed, and dissolution of disintegration, increasing the medicine stability, reducing the dose of auxiliary materials and decreasing cost, with rapid effect and convenient use. It can be buccal as well as deglutition, has remarkable conformity, and is especially suitable for children, older man, sicker in bed or with difficulty of swallowing.
Owner:HONGYI SCI & TECH CO LTD NANCHANG

Propranolol hydrochloride smearing preparation and preparation method and application thereof

The invention provides a propranolol hydrochloride smearing preparation and a preparation method and application thereof. The propranolol hydrochloride smearing preparation is prepared from, by weight, 1%-8% of propranolol hydrochloride, 2.5%-15% of substrate, 2%-10% of skin penetration enhancer, 3%-16% of moisturizing agent, 0.02%-0.2% of bacteriostatic agent and the balance water. The propranolol hydrochloride smearing preparation is small in skin irritation and capable of directly acting on infantile hemangioma ulcer parts to rapidly facilitate ulcer healing and treating hemangioma simultaneously.
Owner:WUHAN UNIV +1

Transdermal drug administering system

The invention discloses a percutaneous give drug system, which comprises: a drug storeroom, the gel drug layer comprises drug, solvent, transdermal accelerating agent and gelatinizing agent; one adsorption layer comprised solvent absorption material of solvent in absorbable drug storeroom; one isolating layer between drug storeroom and adsorption layer, which is of non-woven fabrics or semipermeable membrane to make solvent of gas or liquid pass through successfully; adsorption layer can joint isolating layer of drug storeroom in opposite directions of closing up to skin of drug storeroom. The percutaneous give drug system in this invention can increase drug level in drug storeroom of the system to elevate drug transdermal speed, as well as increase controlled release effect of percutaneous give drug and absolute bioavailability, enhance drug curative effect, decrease drug waste, and depress preparation cost of the system. The invention is fit particular to percutaneous give drug system for water-soluble drug of propranolol hydrochloride, verapamil hydrochloride and chlorpromazine hydrochloride.
Owner:HANGZHOU MINSHENG PHARM CO LTD

Method for resolving propranolol by using menthol-lactic acid hydrophobic eutectic solvent

ActiveCN110483313AOvercoming the disadvantages of being difficult to formSimple compositionOrganic compound preparationOptically-active compound separationMentholSolvent
The invention discloses a method for resolving propranolol by using a menthol-lactic acid hydrophobic eutectic solvent. The method comprises the following steps: uniformly mixing (-)-menthol and L (+)-lactic acid, heating in a stirring state, then stopping stirring, and carrying out heat preservation treatment to obtain a hydrophobic eutectic solvent; adding propranolol hydrochloride into alkali liquid, heating the liquid under stirring, extracting the propranolol, drying and filtering the liquid and evaporating the liquid to remove the solvent to obtain a propranolol free body, and recrystallizing the extract to obtain free propranolol; uniformly mixing water, free propranolol and a hydrophobic eutectic solvent to obtain a mixed solution, and adjusting the pH value to 5.0-9.0; stirring and standing the system to separate the phases to obtain an upper phase and a lower phase; collecting the lower phase and removing the solvent to obtain the R-(+)-propranolol, thereby completing the resolution of propranolol. The method provided by the invention adopts the hydrophobic eutectic solvent, and has the characteristics of environmental protection, simplicity, convenience and high separation degree.
Owner:SOUTH CHINA UNIV OF TECH

Synthesis method of propranolol hydrochloride

The invention discloses a synthesis method of propranolol hydrochloride. The synthesis method of propranolol hydrochloride comprises the following steps: by taking menaphthol and epoxy chloropropane as raw materials, carrying out etherification reaction under an alkaline condition and under the action of a phase transfer catalyst to obtain a key intermediate 3-(1-naphthoxy)-1, 2-epoxypropane; carrying out ring-opening reaction and salifying reaction on the 3-(1-naphthoxy)-1, 2-epoxypropane and isopropylamine under the catalytic action of alkali to obtain a crude propranolol hydrochloride product; and finally refining the crude propranolol hydrochloride product to obtain propranolol hydrochloride with the purity of 99.8% or above. The synthesis method is a preparation method which is shortin synthesis route, simple to operate and suitable for industrial production.
Owner:玉门千华制药有限公司

Compound propranolol hydrochloride oral liquid for treating infantile hemangiomas

The invention relates to compound propranolol hydrochloride oral liquid for treating infantile hemangiomas. The compound propranolol hydrochloride oral liquid comprises the following raw materials byweight of 100-300g of endothelium corneum gigeriae galli, 200-400g of haws, 100-300g of duchesnea indica, 200-300g of bigleaf beautyberry leaves, 200-400g of radix salviae miltiorrhizae, 100-300g of lotus leaves and 30-50g of propranolol hydrochloride. Compared with the prior art, the compound propranolol hydrochloride oral liquid disclosed by the invention has the advantages that the quality andthe effects are notably improved, and the compound propranolol hydrochloride oral liquid is high in cure rate, low in adverse reaction rate, good in mouth feel, easy in infantile administration, smallin dosage and good in biological availability and have enormous social and economic benefits.
Owner:河南百年康鑫药业有限公司

Propranolol hydrochloride tablets and preparation method thereof

The invention relates to a preparation method for propranolol hydrochloride tablets. The method comprises the following steps of: 1) preparing a carrier for solid dispersoid, namely weighing 200 grams of polyethylene glycol (PEG) 6000, dissolving the PEG 6000 in 95 percent (ml / ml) ethanol to obtain an auxiliary material solution, dissolving 100 grams of propranolol hydrochloride in 95 percent (ml / ml) ethanol to obtain a main medicine solution, mixing the auxiliary material solution and the main medicine solution uniformly to obtain a mixed solution, and drying the mixed solution at temperature of between 35 and 55 DEG C under the vacuum with the vacuum degree of less than 10 Pa for 12 to 24 hours; 2) preparing tablets, namely crushing the materials obtained in the step 1), and sieving to obtain solid dispersoid powder; adding a formula dose of dextrin into the solid dispersoid powder, and putting the mixture into a granulator, performing dry mixing for 5 to 10 minutes, adding 40 to 50 percent ethanol serving as an adhesive, and granulating; sieving the materials with a 20-to-30-mesh sieve, granulating in the wet state, and transferring to a fluidized drying machine for drying until the moisture is 5 to 8 percent; and sieving the dried granules with a 20-to-30-mesh sieve, granulating, and mixing the obtained granules and a lubricating agent in a formula uniformly for tabletting.
Owner:常州康普药业有限公司

Applications of compound gymnadenia conopsea (l.) r. br pills in preparation of essential tremor treating drugs

ActiveCN105311387AImprove essential tremor symptomsTo achieve the effect of treating essential tremorOrganic active ingredientsNervous disorderEssential tremorGymnadenia conopsea
The present invention relates to applications of compound gymnadenia conopsea (l.) r. br pills in preparation of essential tremor treating drugs, and belongs to the field of medicine. According to the present invention, the technical prejudice in the application field in the prior art is overcome; and clinical research results show that symptoms of the essential tremor can be significantly improved and the essential tremor treating effect can be achieved by separately using the compound gymnadenia conopsea (l.) r. br pills or combining the compound gymnadenia conopsea (l.) r. br pills and other drugs, the effect of the single use of the compound gymnadenia conopsea (l.) r. br pills is equivalent to the effect of the conventional drug propranolol hydrochloride, and the effect of the combination of the compound gymnadenia conopsea (l.) r. br pills, the nerve calming pills and / or propranolol hydrochloride is superior to the effect of the conventional drug propranolol hydrochloride (P <0.05).
Owner:SHANDONG JINHE DRUG RES DEV

Propranolol enantiomer resolution method

The present invention discloses a propranolol enantiomer resolution method, which comprises: (1) carrying out neutralization alkalization on a (R,S)-propranolol hydrochloride bulk drug by using an alkali solution to prepare (R,S)-propranolol; (2) adopting dehydroabietic acid as a resolution agent, and carrying out a reaction of the (R,S)-propranolol prepared in the step (1) and the dehydroabietic acid in an organic solvent to prepare a propranolol dehydroabietate; and (3) adding the propranolol dehydroabietate in the step (2) to an organic solvent to completely dissolve, and adding a certain amount of an alkali solution to carry out alkalization to prepare the high purity S(-)-propranolol. The propranolol enantiomer resolution method has characteristics of easily available raw materials, low price, high yield, high product purity, less pollution and simple process, and is suitable for industrial production.
Owner:GUANGXI UNIV

Purification method for propranolol hydrochloride key intermediate

The invention discloses a purification method of a propranolol hydrochloride key intermediate, namely 3-(1-naphthoxy)-1,2-epoxypropane. According to the method, lower fatty acid ester and a low-polarity solvent are adopted, and 1-naphthol and epoxy chloropropane are used as raw materials and are subjected to an etherification reaction under the catalytic action of N,N-diisopropylethylamine to obtain the key intermediate 3-(1-naphthoxy)-1,2-epoxypropane. According to the invention, a reaction system is subjected to extraction washing and column chromatographic purification so as to remove organic impurities and inorganic impurities contained in the reaction system; the method is simple to operate and beneficial to recovery and environmental protection, overcomes the problems of strict requirements on instruments and equipment and high-boiling pollution caused by adopting a high-vacuum and high-temperature repeated reduced-pressure distillation method in the prior art, and remarkably improve the yield and the quality of the key intermediate. The purification method is more beneficial to subsequent preparation of propranolol hydrochloride, and is suitable for large-scale industrial production.
Owner:HUAZHONG PHARMA

Medicinal composition for preparing orally-taken sustained release preparation

The invention discloses a medicinal composition for preparing an orally-taken sustained-release preparation. Active ingredients of the medicinal composition comprises amlodipine besylate or propranolol hydrochloride or salbutamol sulfate. A sustained release polymer in the medicinal composition is a cellulose derivative, an acrylic acid or methylacrylic acid derivative, or a carbohydrate-based polymer and the like. The sustained release solid composition containing the amlodipine besylate, or the propranolol hydrochloride or the salbutamol sulfate can be prepared into preparation forms such as sustained-release watered pills, various skeleton sustained release preparations, coating sustained release preparations, sustained release capsules, sustained release medical membranes, resin drug sustained release preparations, liquid sustained release preparations.
Owner:JIANGSU YABANG AIPUSEN PHARMA

Felodipine propranolol hydrochloride compound preparation and preparation method thereof

The invention relates to a felodipine propranolol hydrochloride compound preparation and a preparation method thereof. The felodipine propranolol hydrochloride compound preparation comprises an inner layer and an outer layer, wherein the active ingredient of the inner layer is propranolol hydrochloride; the active ingredient of the outer layer is felodipine; and the outer layer is wrapped outside the inner layer. The felodipine and propranolol hydrochloride are combined for use, so that the antihypertensive effect can be achieved, and propranolol hydrochloride can resist the effect of heart rate increase caused by long-term administration of felodipine.
Owner:NKD PHARMA CO LTD

Propranolol hydrochloride tablets and preparation method thereof

The invention relates to a preparation method for propranolol hydrochloride tablets. The method comprises the following steps of: 1) preparing a carrier for solid dispersoid, namely weighing 200 grams of polyethylene glycol (PEG) 6000, dissolving the PEG 6000 in 95 percent (ml / ml) ethanol to obtain an auxiliary material solution, dissolving 100 grams of propranolol hydrochloride in 95 percent (ml / ml) ethanol to obtain a main medicine solution, mixing the auxiliary material solution and the main medicine solution uniformly to obtain a mixed solution, and drying the mixed solution at temperature of between 35 and 55 DEG C under the vacuum with the vacuum degree of less than 10 Pa for 12 to 24 hours; 2) preparing tablets, namely crushing the materials obtained in the step 1), and sieving to obtain solid dispersoid powder; adding a formula dose of dextrin into the solid dispersoid powder, and putting the mixture into a granulator, performing dry mixing for 5 to 10 minutes, adding 40 to 50 percent ethanol serving as an adhesive, and granulating; sieving the materials with a 20-to-30-mesh sieve, granulating in the wet state, and transferring to a fluidized drying machine for drying until the moisture is 5 to 8 percent; and sieving the dried granules with a 20-to-30-mesh sieve, granulating, and mixing the obtained granules and a lubricating agent in a formula uniformly for tabletting.
Owner:常州康普药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products